Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
3-Pyridylamide oxime serves as a synthetic intermediate in pharmaceutical synthesis, facilitating the development of various bioactive compounds. It is primarily utilized in the preparation of pyridine-based pharmaceuticals and is valuable in medicinal chemistry for its role in drug discovery and development. Its unique chemical structure enables researchers to explore novel therapeutic agents and optimize pharmacological properties. -
Drug Impurity
Rivastigmine impurity 8 is a chemical impurity associated with the cholinesterase inhibitor rivastigmine. This impurity serves as a reference standard for quality control and analytical applications in pharmaceutical research. It facilitates the identification and quantification of impurities in drug formulations, contributing to the assessment of drug purity and safety in clinical and preclinical studies. -
Drug Impurity
Progesterone Impurity 4, also known as 20-Dihydroprogesterone Acetate, is a known impurity of the hormone progesterone. This compound may be used in quality control and analytical studies to assess the purity of progesterone in pharmaceutical formulations. Its presence can affect the stability and efficacy of progesterone-based products, making it relevant in pharmaceutical and biochemical research applications. -
Drug Intermediate
2-Methyl-1H-pyrrolo[2,3-b]pyridine serves as a valuable drug intermediate in organic synthesis, particularly in the development of complex pharmaceutical compounds. This heterocyclic organic molecule is instrumental in the construction of various targeted therapies, including BMS-645737, a potent inhibitor of VEGFR-2. Its utility in drug design underscores its significance in advancing research in medicinal chemistry and therapeutic applications. -
Drug Impurity
Thioridazine impurity 3, also known as Thioridazine disulfone, is a chemical impurity associated with thioridazine. This compound serves as a vital analytical reference for the characterization and quality control of thioridazine formulations. Its identification is essential for drug development studies and ensuring the integrity of pharmaceutical products containing thioridazine. -
Drug Impurity
Candesartan impurity 30 is a chemical impurity associated with Candesartan, an angiotensin II receptor antagonist. This compound is utilized in quality control and analytical studies to ensure the purity of Candesartan in pharmaceutical formulations. Its evaluation is crucial for maintaining compliance with regulatory standards and for assessing the safety and efficacy of the drug in research applications. -
Drug Impurity
Clindamycin impurity 1 is a known impurity associated with the antibiotic clindamycin. Its presence is primarily of concern in pharmaceutical research and quality control, as it may impact the efficacy and safety profile of clindamycin formulations. This reagent is utilized in analytical studies to ensure the purity of clindamycin and to support regulatory compliance in drug development. -
Drug Impurity
Famotidine impurity 3 hydrochloride is a known impurity of famotidine hydrochloride, primarily utilized in the evaluation of pharmaceutical quality and safety. This compound serves as an important reference material for stability studies, formulation analysis, and impurity profiling in drug development. Its presence is critical for assessing the purity of famotidine formulations and ensuring compliance with regulatory standards in pharmaceutical research. -
Drug Impurity
Afatinib impurity 2 is a characterized impurity associated with the drug Afatinib, a potent irreversible inhibitor of the ErbB family of receptor tyrosine kinases. This impurity is essential for quality control and regulatory compliance in the synthesis of Afatinib, facilitating research on its pharmacological properties and therapeutic applications in oncology. Its presence may impact the overall profile of the parent compound and is crucial for analytical studies in drug development. -
Drug Impurity
Glipizide impurity 14 is a known impurity of the antidiabetic agent Glipizide, primarily affecting the drug's pharmacological profile. This impurity is important for analytical and quality control applications in pharmaceutical research and formulation development. Its characterization is essential for ensuring the safety and efficacy of Glipizide products in clinical settings. -
Drug Impurity
Ranolazine impurity 2 is a chemical impurity associated with the antianginal agent Ranolazine. This compound is utilized in quality control and analytical studies to ensure the purity and safety of pharmaceutical formulations. Its presence and characterization are essential for establishing compliance with regulatory standards in drug development processes. -
Drug Impurity
Famotidine impurity 6 is a chemical impurity associated with Famotidine, a histamine H2-receptor antagonist. This compound is primarily utilized in drug quality control and analysis to ensure the purity and safety of pharmaceutical formulations. Researchers can deploy this reagent in the study of drug synthesis processes and the identification of impurities in H2-antagonist medications. -
Drug Impurity
10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)-2-(trifluoromethyl)-10H-phenothiazine 5-oxide, also known as Fludarabine Impurity, is a chemical impurity derived from Fludarabine. This compound retains a phenothiazine structure, demonstrating potential interactions within biological systems. It is primarily utilized in pharmaceutical research to assess purity and identify potential side effects in drug development processes, contributing to the safety and efficacy profiles of therapeutic agents. -
Drug Impurity
Anastrozole impurity 10 is a chemical impurity associated with Anastrozole, which is a non-steroidal aromatase inhibitor primarily targeting the aromatase enzyme. This impurity serves as a critical marker for the quality control and characterization of Anastrozole and related compounds. It is essential for pharmaceutical research and development, particularly in studies evaluating the efficacy and safety of aromatase inhibitors in cancer therapeutics. -
Drug Impurity
Flurbiprofen impurity 5 is a known impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Flurbiprofen. This compound is utilized in research to study the effects and behaviors of drug impurities, contributing to the understanding of pharmaceutical quality and efficacy. Its analysis is essential for ensuring the safety and effectiveness of drug formulations, particularly within the context of regulatory compliance and drug development. -
Drug Impurity
Famotidine impurity 10 is a known impurity associated with the histamine H2 receptor antagonist famotidine. This compound is utilized primarily in the analysis of drug purity and stability. Its identification is critical in ensuring the quality and safety of pharmaceutical formulations containing famotidine. Researchers may employ this reagent in the assessment of synthesis methods, formulation development, and regulatory compliance. -
Drug Impurity
Mebendazole impurity 6, also known as 5-Benzoyl-2-benzimidazolinone, serves as a drug impurity of Mebendazole. It is utilized in pharmacological studies to ensure the quality and safety of Mebendazole formulations. Understanding this impurity is critical for evaluating the compound's stability and regulatory compliance in drug development. -
Pranoprofen Impurity
2-(5-Oxo-5H-Chromeno[2,3-b]pyridin-7-yl)propanoic acid is a characterized impurity associated with Pranoprofen, a nonsteroidal anti-inflammatory drug. This compound serves as a useful reference standard in analytical chemistry for the assessment of drug purity and stability. Its presence in research can assist in the evaluation of pharmacological profiles and potential safety assessments of pharmaceutical formulations. -
Drug Impurity
Bupropion impurity 3 is a chemical byproduct associated with the synthesis of bupropion. It serves as a crucial reference standard for assessing the purity and quality of bupropion formulations in pharmaceutical research. The compound is essential for analytical studies focusing on the identification and quantification of drug impurities during the development and quality control processes of bupropion. -
Drug Impurity
Cinacalcet impurity 5 is a chemical impurity associated with the drug Cinacalcet, which functions as a calcimimetic agent targeting the calcium-sensing receptor (CaSR). This impurity may serve as a reference standard in quality control and analytical laboratories to ensure the purity of Cinacalcet formulations. Its characterization is crucial for maintaining stringent pharmaceutical standards and for research applications involving drug stability and degradation studies. -
Drug Impurity
Raloxifene impurity 3 is a structural impurity associated with the selective estrogen receptor modulator Raloxifene. It serves as a key reference standard for the assessment of drug purity and formulation quality control in pharmaceutical research. The compound can be utilized in various analytical techniques to ensure compliance with regulatory standards in drug development. -
Drug Impurity
Candesartan impurity 29 is a byproduct associated with the synthesis of Candesartan, an angiotensin II receptor antagonist. This impurity may be utilized in research to assess the purity and stability of Candesartan formulations. Its characterization is essential for quality control and regulatory compliance in pharmaceutical development. -
Drug Impurity
Azilsartan impurity 4 is a chemical impurity associated with the antihypertensive agent Azilsartan. Its characterization is essential for ensuring the quality and safety of drug formulations. This impurity may be used in the development and validation of analytical methods, providing crucial insights into the stability and integrity of Azilsartan compounds in pharmaceutical research. -
Drug Impurity
Clopidogrel impurity 5, also known as Clopidogrel impurity D, is a structural impurity associated with the pharmaceutical compound Clopidogrel. This reagent is critical for studies assessing the purity and quality of Clopidogrel formulations. It is commonly utilized in pharmaceutical research to investigate potential impurities that may influence drug efficacy and safety profiles. -
Drug Impurity
Edoxaban impurity 15 (Edoxaban N-oxide) serves as a drug impurity associated with Edoxaban. This compound is significant for analytical studies concerning drug quality and stability, as well as for assessing the safety and efficacy profiles of Edoxaban formulations. Its characterization is crucial for regulatory compliance in pharmaceutical development and quality control processes. -
Bupivacaine Impurity
1-(2,6-Dimethylphenyl)-6,7-dihydro-1H-azepin-2(5H)-one is identified as an impurity of Bupivacaine, a widely used local anesthetic. This compound may be utilized in quality control and analytical studies to assess the purity of Bupivacaine formulations. Its presence and characterization are essential for ensuring the safety and efficacy of anesthetic preparations in clinical applications. -
Drug Intermediate
4-(1-Piperazinyl)-1H-Indole hydrochloride is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound plays a crucial role in the development of various drugs by facilitating the formation of indole-based scaffolds. Its structural attributes support research into bioactive molecules, making it valuable for medicinal chemistry applications. -
Drug Impurity
Trazodone impurity 17 is a specific impurity of the antidepressant Trazodone, primarily associated with the compound's synthesis. It is essential for researchers to evaluate the quality and safety of pharmaceutical formulations, as impurities can influence drug efficacy and safety profiles. This reagent is valuable for analytical studies, quality control, and pharmaceutical development, providing critical insights into the compound's purity and stability. -
Drug Impurity
Moxifloxacin impurity 9 is a drug impurity derived from the antibiotic Moxifloxacin. As an impurity, it is important for quality control and stability testing in pharmaceutical research and development. Its characterization contributes to understanding the synthesis processes and ensuring the safety and efficacy of Moxifloxacin formulations. -
Drug Intermediate Control
Ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-carboxylate is a synthetic intermediate that serves as an essential building block in pharmaceutical synthesis. This compound is designed for applications in drug development, facilitating the formation of various active pharmaceutical ingredients. Its versatile structural features make it a valuable reagent in medicinal chemistry and drug formulation processes. -
Drug Impurity
Rivaroxaban impurity 13 is a chemical impurity associated with the anticoagulant Rivaroxaban. It is utilized primarily in analytical chemistry for method development and validation, particularly in the assessment of drug purity and quality control. This impurity is essential for researchers examining the stability and safety profiles of pharmaceutical formulations containing Rivaroxaban. -
Drug Impurity
Pantoprazole impurity 26 is a characterized impurity associated with Pantoprazole, a proton pump inhibitor. Its presence is of considerable importance in the pharmaceutical industry for ensuring drug quality and compliance with regulatory standards. This compound is often utilized in analytical research for stability studies, purity assessments, and formulation development. -
Drug Impurity
Canagliflozin impurity 12 is a chemical impurity associated with the antidiabetic agent Canagliflozin, which primarily targets the sodium-glucose co-transporter 2 (SGLT2). This impurity is relevant for quality control and pharmacological assessments in the development of Canagliflozin and related compounds. Research applications include method validation, stability testing, and assessing the purity of pharmaceutical formulations. -
Drug Impurity
Solifenacin impurity 10 is a drug impurity associated with Solifenacin. This compound is relevant for analytical chemistry and quality control studies in pharmaceutical research. It serves as a reference standard in the identification and quantification of impurities during Solifenacin synthesis, ensuring compliance with regulatory standards in drug development. -
Perphenazine Impurity
4-[3-(10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol is identified as a Perphenazine impurity. It shares structural similarities with Perphenazine, a typical antipsychotic agent, and serves as a valuable reference compound for analytical studies. This impurity can be utilized in research applications focusing on pharmaceutical development, quality control, and stability testing of Perphenazine-containing formulations. -
Drug Intermediate Control
7-Piperazin-1-yl-thieno[2,3-c]pyridine hydrochloride is a synthetic chemical compound that serves as a key intermediate in pharmaceutical synthesis. Its structure and properties make it valuable for the development of various drug candidates. This reagent is commonly utilized in chemical research to explore new therapeutic avenues and enhance the efficacy of drug formulations. -
Lacosamide Impurity
(Rac)-Desmethyl lacosamide is a known impurity of lacosamide and serves as a significant intermediate in the synthesis of this anticonvulsant drug. This compound can be used in chemical research to study the properties and effects of lacosamide and its derivatives. Its characterization is essential for ensuring the purity and efficacy of lacosamide formulations in therapeutic applications. -
Drug Impurity
Clopidogrel impurity 8 is a metabolite impurity associated with the antiplatelet agent Clopidogrel. This compound is significant for quality control and analytical studies in pharmaceutical research, particularly in assessing the purity of Clopidogrel formulations. It serves as a valuable reference standard for the identification and quantification of impurities in drug development and stability testing. -
Drug Impurity
Fusidic acid impurity 1, also known as 16-Epidesacetylfusidic acid, is a chemical impurity associated with fusidic acid. This compound serves as a significant marker in the quality control of fusidic acid production, aiding in the purification and identification of active pharmaceutical ingredients. Research applications include its use in stability studies and the analysis of drug formulation quality in pharmaceutical development. -
Drug Impurity
Betamethasone acetate impurity 1, also known as Betamethasone 11,21-diacetate, is characterized as a drug impurity of Betamethasone acetate. Its presence can impact the efficacy and safety profiles of pharmaceutical formulations. This compound is essential for quality control and analytical research, providing insight into the purity and stability of corticosteroid products. -
Drug Impurity
Tenofovir impurity 1, also known as Tenofovir impurity E, is a significant impurity of the antiretroviral drug Tenofovir. It is essential for quality control and analytical studies during the synthesis of Tenofovir. Researchers can utilize this compound to assess the purity and stability of Tenofovir formulations in pharmaceutical development and regulatory compliance. -
Drug Impurity
Salmeterol impurity 7, also known as Salmeterol impurity H, is a defined impurity of the bronchodilator Salmeterol. This compound is utilized primarily in drug quality control and analytical studies to ensure the purity and efficacy of pharmaceutical formulations. Its presence in Salmeterol formulations may affect therapeutic outcomes, making it essential for rigorous quality assurance processes in pharmaceutical research and development. -
Drug Impurity
Naproxen impurity 6, also known as Naproxen Nitrile impurity, is a chemical impurity associated with the nonsteroidal anti-inflammatory drug (NSAID) Naproxen. This compound is primarily utilized in the analysis of drug formulations and quality control to ensure the purity and safety of pharmaceutical products. Its understanding is crucial for regulatory compliance and for studying the degradation pathways of Naproxen during storage and processing. -
Drug Impurity
Atorvastatin impurity 7 calcium is a known impurity associated with Atorvastatin calcium, a widely used statin for cholesterol management. As a research reagent, it serves as a reference standard in the characterization and analysis of Atorvastatin formulations. Its identification is crucial for ensuring the quality and safety of pharmaceutical products containing Atorvastatin. -
Drug Impurity
Flurbiprofen impurity 2 is a known impurity of the nonsteroidal anti-inflammatory drug (NSAID) Flurbiprofen. This compound is relevant for quality control and regulatory compliance in pharmaceutical development, as it highlights potential variations in drug purity. It can be utilized in research applications focused on the analysis of drug formulations and the assessment of the safety and efficacy profiles of NSAIDs. -
Drug Impurity
Telmisartan impurity 7, also known as Telmisartan bromo ethyl ester, functions primarily as a drug impurity associated with the pharmaceutical compound Telmisartan. This compound is important for quality control and analytical studies, enabling researchers to assess the purity and stability of Telmisartan formulations. Its analysis can aid in ensuring compliance with regulatory standards in drug development and manufacturing processes. -
Drug Intermediate
Nordiazepam uncyclized intermediate hydrochloride is a prodrug intermediate utilized in the synthesis of Nordiazepam. This compound plays a crucial role in the development of anxiolytic and sedative agents by modulating GABAergic activity in the central nervous system. Its applications are primarily focused on drug discovery and development within the pharmaceutical industry, particularly in the formulation of therapeutic agents for anxiety and sleep disorders. -
Drug Impurity
Cinacalcet impurity 1 is a chemical impurity associated with Cinacalcet, a calcimimetic agent targeting the calcium-sensing receptor. This impurity is primarily used in pharmaceutical research to evaluate the purity and formulation of Cinacalcet, ensuring compliance with quality control protocols in drug development. It serves as an important reference standard for analytical purposes. -
Drug Impurity
N-(4-(N-(Cyclohexylcarbamoyl)sulfamoyl)phenethyl)-6-methylpyrazine-2-carboxamide, known as Glipizide Impurity, serves as a chemical impurity in the synthesis of the antidiabetic agent Glipizide. This compound can be utilized to investigate the stability, purity, and quality of pharmaceutical formulations containing Glipizide. Researchers studying drug metabolism and impurity profiles in pharmaceutical contexts may find this reagent valuable for their analytical and quality control applications. -
Drug Impurity
Rivaroxaban impurity 3 is a known impurity associated with the anticoagulant Rivaroxaban. This compound is utilized primarily in analytical chemistry for the quality control and characterization of Rivaroxaban formulations. Its identification and quantification are essential for ensuring the purity and safety of pharmaceutical products containing Rivaroxaban.
